The 10/31/24 #JournalClub article 2 presented "Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline-trospium) in schizophrenia (EMERGENT-2) in the USA." The recording is available free to all AAPP members.
Journal Club